Genesis Healthcare Announces Effective Date of Chapter 11 Plan Following Consummation of Sale to West State Street
Genesis Healthcare Announces Effective Date of Chapter 11 Plan Following Consummation of Sale to West State Street
Genesis Healthcare, Inc. (“Genesis”) today announced that its chapter 11 plan became effective, following the closing of the sale of substantially all of its operating assets to 101 W. State Street, LLC (“West State Street”) on October 14, 2026.
On behalf of the Board of Directors, the Company thanks its management team, its employees and staff for their focus and dedication throughout the chapter 11 process. Despite a long and complex case, the Company’s financial and quality of care metrics continued to improve substantially.
“The employees and staff were the heart of this Genesis organization. Throughout this complex bankruptcy case, they stayed focused on the people in their care, kept operations strong, and continued the operational turnaround that remained Genesis’ focus prior to, and during, the bankruptcy process,” said David Harrington, outgoing Chairman of the Board. “On behalf of the Board, I thank them for their commitment and hard work. We wish West State Street every success as it carries these operations into the future.”
Advisors
McDermott Will & Schulte served as legal counsel, Ankura Consulting provided financial restructuring and Chief Restructuring Officer services (Russell A. Perry and Louis E. Robichaux IV, Co-CROs), and Jefferies served as exclusive investment banker.
ABOUT GENESIS HEALTHCARE, INC.
Genesis HealthCare, Inc. is a holding company with affiliates that previously operated skilled nursing facilities and assisted/senior living communities. Its subsidiaries also specialized in contract rehabilitation therapy, respiratory therapy, physician services, and accountable care.
MEDIA CONTACT
mediainquiry@genesishcc.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20261023067917/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
Why This Vanguard ETF Is One of the Best
6 ETFs To Diversify Away From AI
The Best AI Stocks to Buy Now
United States